M17: Aktuálne problémy liečby karcinómu prostaty(F.Goncalvos - Bratislava, Valné zhromaždenie EUS07)

M18:Sexualita a rakovina prostaty (M. Horňák- Bratislava, Valné zhromaždenie EUS 07)

M19:Europa Uomo (Louis Denis - Antwerpy, Monaco 06)

M20: Overdetection of prostate cancer (Chris H.Bangma, ESMO, 2007, Brusel)

M21: EU European Prostate Pasport - Recommendations from Berlin, 2007)

M22: Prostate Cancer Bridging the GAP in Europe (ESMO Patient Coalition Forum, Louis Denis, 2007, Brusel)

M23: What´s New in Prostate Cancer - (EAU, Berlin, J.Yee, 2007)

M24: The Endothelin Axis: Oncogenic Mechanism - (EAU - Europa Uomo, A.von Eschenbach, 2007)

M25: Podporná liečba karcinomu stravou - (2.Medzinár.onkolog.konf.Znojmo, V.Koprda, nov.2006)

M26: Biopsia prostaty (J.Ľupták, 2.ZUS, Štrbské pleso, jan.2008)

M27: Karcinóm prostaty (B.Eliáš, 2.ZUS, Štrbské pleso, jan.2008)

M28: Včasná diagnostika CaP pri nízkom PSA (V.Student, 2.ZUS, Štrbské pleso, jan.2008)

M29: Lokalizovaný a lokálne pokročilý karcinóm prostaty (V.Kliment, VZ EUS Bratislava,12.feb.08)

M30: Zápisnica z Valného zhromaždenia OZ Europa Uomo Slovensko, 12.februára 2008

M31: EU-The European Prostate Cancer Coalition (J.Moreau & L.Denis, OECI Workshop, Avignon, 14.3.05)

M32: Management of Senior Adults with Prostate Ca (L.Denis, Europa Uomo, Milan, 27.3.08)

M33: Recent Advances in Prostate Cancer.Part 1. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)

M34: Recent Advances in Prostate Cancer.Part 2. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)

M35: Recent Advances in Prostate Cancer.Part 3. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)

M36: Recent Advances in Prostate Cancer.Part 4. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)

M37: PROCABIO - the treatment of ca prostate by biomarkers (C.Bangma, EAU, Brussels, 28.3.08)

M38: Improving Patient Participation and Information on Clinical Trials(ECPC, J Giessler, Brussel, 8.4.2008)

M39: Cancer Patients - Partners for Change (ECPC, H. Sunseth, Brussel, 8.4.2008)

M41: What a patient expects from his pharmacist (L.Denis, Luxembourgh, 26.9.2008)

M43: WWPCC Geneva (Hudson 28_8_2008)

M44: ESMO Stockholm Sept 08(Van Poppel)

M45: Management biochemickej recidívy po kuratívnej liečbe karcinómu prostaty, J.Breza, VZ OZ EUS, 18.2.2009

M51: Active surveillance and the PRIAS protocol, J.Roobol, Krakow, 9.2.2009

M52: Controversies in Prostate Diseases, L.Denis, Krakow, 6.2.09

M53: Multiprofessional disciplinary approach (Valdagni, GA EU, Stockholm, 19.3.09)

M54: Advnces in the managementsof BPH/LUTS(H.Chaple, Sheffield Univ., GA EU, Stockholm, 19.3.09)

M55: Screening, early diagnosis, treatment, active surveillance for prostate cancer (Ch.C.Bangma, Rotterdam, 2009)

M57: The Future of Prostate Cancer: Urologistś and European Perspectives (PA Abrahamson,EAU Stockholm 2009)

M58: New Developments in the Treatment of HRPC (B.Tomba, EAU Stockholm 2009)

M59: Adjuvant or Salvage Radiotherapy after Radical Prostatectomy(M.Wirth,TU Dresden, 2009)

M64: GA EU 09 - Report of the Secretary (L.Denis, Stockholm)

M65: GA EU 09 - Prostate Cancer Research in Europe (G.Feick, Stockholm)

M66: GA EU 09 - A Guide to Starting a PCSHS Group (M.Lockett, Stockholm)

Prostate Cancer Final report for HCP

Why HRQoL is important to Patients (nov 26 Brussels

M67-BPH a QoL- Bujdak P-PresKonf. 2010 Bratislava

M68-Týždeň urológie -Kliment V- PresKonf. 2010 Bratislava

M69-BPH-Baláž V-PresKonf. 2010 Bratislava

EUS-M70- CaP a SEX

EUS-M71- Europa Uomo 2011

EUS-M72- EU-S-VZ11-Uznesenie

EUS-M73- EU-S-VZ11-Zápisnica

EUS-M74- EU-S- Riadiace orgány OZ EUS 2011

EUS-M75- Výzva k poukázaniu 2% z daní 2010

EU-S-Pozvánka na VZ 12

Pooled analysis of 2 protocols of intermittent hormonal therapy, in advanced prostate cancer

Becoming a qualified Advocate

Skriningové vyšetrenie karcinómu prostaty

Biopsia prostaty

PARKER (EAU 2012 EUomo)

ROOBOL (Paris 120225)

VALDAGNI (EUomo EAU Paris ESO Pca Programme 2012)

BELLARDITA (Paris 120236)